+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Radiotherapy Market by Product, By Technology for Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal cancer, Gynecological Cancer, Penile Cancer and Other Cancer

  • ID: 4853184
  • Report
  • March 2017
  • Region: Global
  • 110 pages
  • Zion Market Research

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers forecast and analysis for the radiotherapy market on a global and regional level. The study provides historic data from 2014 along with a forecast for 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the radiotherapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the radiotherapy market on a global level.

In order to give the users of this report a comprehensive view on the radiotherapy market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product, technology, and applications segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.

The study provides a decisive view on the radiotherapy market by segmenting the market based on product, technology, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on product, radiotherapy market has been segmented into external beam radiation therapy, internal radiation therapy (brachytherapy), and systemic radiation therapy. External beam radiation therapy is further sub-segmented into compact advanced radiotherapy systems (Cyberknife, Gamma knife, and Tomotherapy), proton therapy systems (Cyclotron and Synchrotron) and electron emitting high energy linear accelerators (Linac). Internal radiation therapy is further sub-classified into seeds, applicators & after leaders and electronic brachytherapy. External beam radiation therapy holds the maximum share of global radiotherapy market.

Based on technology radiotherapy market is classified into external beam radiation therapy (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, Tomotherapy, 3D Conformal Radiotherapy (3D CRT) and Volumetric Modulated Arc Therapy (VMAT)), internal radiation therapy (Low Dose Rate and High Dose Rate), and systemic radiation therapy.

Based on applications external beam radiation therapy segment is classified into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer and other. Internal radiation therapy is classified into prostate cancer, gynecological cancer, breast cancer, penile cancer and other.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for radiotherapy based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Elekta AB, Varian Medical Systems, Accuray Incorporated, IBA Worldwide, IsoRay Medical, Inc., Nordion, Inc., Raysearch Laboratories, Mevion Medical Systems, Mitsubishi Electric Corporation and C. R. Bard, Inc. among others.

This report segments the global radiotherapy market as follows:

Global Radiotherapy Market: By Product

  • External beam radiation therapy
  • Compact Advanced Radiotherapy Systems
  • Cyberknife
  • Gamma Knife
  • Tomotherapy
  • Proton Therapy Systems
  • Cyclotron
  • Synchrotron
  • Electron Emitting High Energy Linear Accelerators (Linac)
  • Internal Radiation Therapy/Brachytherapy
  • Seeds
  • Applicators & Afterloaders
  • Electronic Brachytherapy
  • Systemic Radiation Therapy

Global Radiotherapy Market: By Technology

  • External Beam Radiation Therapy
  • Image-Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Stereotactic Technology
  • Proton Beam Therapy
  • Tomotherapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Beam Radiotherapy
  • Low Dose Rate
  • High Dose Rate
  • Systemic Radiation Therapy

Global Radiotherapy Market: By Application

  • External Beam Radiation Therapy
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head & Neck Cancer
  • Colorectal Cancer
  • Other
  • Internal Radiation Therapy
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Penile Cancer
  • Other

Global Radiotherapy Market: By Region

  • North America
  • U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global radiotherapy market, 2014 – 2022 (USD Billion)
    • 2.2. Global radiotherapy market : Snapshot
  • Chapter 3. Radiotherapy– Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global radiotherapy market drivers: Impact analysis
      • 3.2.2. Increasing incidences of cancer
      • 3.2.3. Increasing geriatric population
    • 3.3. Market restraints
      • 3.3.1. Global radiotherapy market restraints: Impact analysis
      • 3.3.2. Lack of infrastructure
    • 3.4. Opportunities
      • 3.4.1. Technological advancements in radiotherapy products
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by technology segment
      • 3.6.3. Market attractiveness analysis, by applications segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Radiotherapy Market – Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global radiotherapy market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  • Chapter 5. Global Radiotherapy Market – Product Segment Analysis
    • 5.1. Global radiotherapy market: Product overview
      • 5.1.1. Global radiotherapy market revenue share, by Product, 2016 and 2022
    • 5.2. External beam radiation therapy
      • 5.2.1. Global External beam radiation therapy market, 2014 – 2022(USD Billion)
      • 5.2.2. Compact Advanced Radiotherapy Systems
        • 5.2.2.1. Global Compact Advanced Radiotherapy Systems market , 2014 – 2022(USD Billion)
        • 5.2.2.2. Global Cyberknife market, 2014 – 2022(USD Billion)
        • 5.2.2.3. Global Gamma knife market, 2014 – 2022(USD Billion)
        • 5.2.2.4. Global Tomotherapy market, 2014 – 2022(USD Billion)
      • 5.2.3. Proton Therapy Systems
        • 5.2.3.1. Global Proton Therapy Systems market, 2014 – 2022(USD Billion)
        • 5.2.3.2. Global Cyclotron market, 2014 – 2022(USD Billion)
        • 5.2.3.3. Global Synchrotron market, 2014 – 2022(USD Billion)
      • 5.2.4. Electron Emitting High Energy Linear Accelerators (Linac)
        • 5.2.4.1. Global Electron Emitting High Energy Linear Accelerators (Linac) market, 2014 – 2022(USD Billion)
    • 5.3. Internal Radiation Therapy/Brachytherapy
      • 5.3.1. Global Internal Radiation Therapy/Brachytherapy market, 2014 – 2022(USD Billion)
      • 5.3.2. Global seeds market, 2014 – 2022(USD Billion)
      • 5.3.3. Global Applicators & Afterloaders market, 2014 – 2022(USD Billion)
      • 5.3.4. Global Electronic Brachytherapy market, 2014 – 2022(USD Billion)
    • 5.4. Systemic Radiation Therapy
      • 5.4.1. Global Systemic Radiation Therapy market, 2014 – 2022(USD Billion)
  • Chapter 6. Global Radiotherapy Market – Technology Segment Analysis
    • 6.1. Global radiotherapy market: Technology overview
      • 6.1.1. Global radiotherapy market revenue share, by technology, 2014 and 2020
    • 6.2. External beam radiation therapy
      • 6.2.1. Global External beam radiation therapy market , 2014 – 2022(USD Billion)
      • 6.2.2. Global Image-Guided Radiotherapy (IGRT) market, 2014 – 2022(USD Billion)
      • 6.2.3. Global Intensity Modulated Radiotherapy (IMRT) market, 2014 – 2022(USD Billion)
      • 6.2.4. Global Stereotactic Technology market, 2014 – 2022(USD Billion)
      • 6.2.5. Global Proton Beam Therapy market, 2014 – 2022(USD Billion)
      • 6.2.6. Global Tomotherapy market, 2014 – 2022(USD Billion)
      • 6.2.7. Global 3D Conformal Radiotherapy (3D CRT) market, 2014 – 2022(USD Billion)
      • 6.2.8. Global Volumetric Modulated Arc Therapy (VMAT) market, 2014 – 2022(USD Billion)
    • 6.3. Internal Radiation Therapy
      • 6.3.1. Global Internal radiation therapy market, 2014 – 2022(USD Billion)
      • 6.3.2. Global Low Dose Rate Radiotherapy market , 2014 – 2022 (USD Billion)
      • 6.3.3. Global High Dose Rate Radiotherapy market , 2014 – 2022 (USD Billion)
    • 6.4. Systemic Radiation Therapy
      • 6.4.1. Global Systemic Radiation Therapy market, 2014 – 2022(USD Billion)
  • Chapter 7. Global Radiotherapy Market – Application Segment Analysis
    • 7.1. Global radiotherapy market: Application overview
      • 7.1.1. Global radiotherapy market revenue share, by application, 2014 and 2020
    • 7.2. External beam radiation therapy
      • 7.2.1. Global External beam radiation therapy market for prostate cancer, 2014 – 2022(USD Billion)
      • 7.2.2. Global External beam radiation therapy market for breast cancer, 2014 – 2022(USD Billion)
      • 7.2.3. Global External beam radiation therapy market for lung cancer, 2014 – 2022(USD Billion)
      • 7.2.4. Global External beam radiation therapy market for head & neck cancer, 2014 – 2022(USD Billion)
      • 7.2.5. Global External beam radiation therapy market for colorectal cancer, 2014 – 2022(USD Billion)
      • 7.2.6. Global External beam radiation therapy market for other cancers, 2014 – 2022(USD Billion)
    • 7.3. Internal Radiation Therapy
      • 7.3.1. Global Internal Beam Radiotherapy market for prostate cancer, 2014 – 2022(USD Billion)
      • 7.3.2. Global Internal Beam Radiotherapy market for gynecological cancer, 2014 – 2022(USD Billion)
      • 7.3.3. Global Internal Beam Radiotherapy market for breast cancer, 2014 – 2022(USD Billion)
      • 7.3.4. Global Internal Beam Radiotherapy market for penile cancer, 2014 – 2022(USD Billion)
      • 7.3.5. Global Internal Beam Radiotherapy market for other cancers, 2014 – 2022(USD Billion)
  • Chapter 8. Global Radiotherapy Market – Regional Segment Analysis
    • 8.1. Global radiotherapy market: Regional overview
      • 8.1.1. Global radiotherapy market revenue share, by region, 2015 and 2021
    • 8.2. North America
      • 8.2.1. North America radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.2.2. North America radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.2.3. North America radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.2.4.2. U.S. radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.2.4.3. U.S. radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.3.2. Europe radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.3.3. Europe radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.3.4.2. U.K. radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.3.4.3. U.K. radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.3.5. Germany
        • 8.3.5.1. Germany radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.3.5.2. Germany radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.3.5.3. Germany radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.3.6.2. France radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.3.6.3. France radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.4.2. Asia Pacific radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.4.3. Asia Pacific radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.4.4.2. China radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.4.4.3. China radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.4.5.2. Japan radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.4.5.3. Japan radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.4.6.2. India radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.4.6.3. India radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.5.2. Latin America radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.5.3. Latin America radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.5.4.2. Brazil radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.5.4.3. Brazil radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.6.2. Middle East and Africa radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.6.3. Middle East and Africa radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
  • Chapter 9. Company Profile
    • 9.1. Elekta AB
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Varian Medical Systems
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Accuray Incorporated
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. IBA Worldwide
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. IsoRay Medical, Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Nordion, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Raysearch Laboratories
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Mevion Medical Systems
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Mitsubishi Electric Corporation
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. C. R. Bard, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
Note: Product cover images may vary from those shown
Adroll
adroll